# Concurrent uveitis in monozygotic twins in the context of systemic sarcoidosis

## TL;DR

Two identical twins developed eye inflammation at the same time, with one also having sarcoidosis, suggesting shared genetic and environmental factors may play a role.

## Contribution

First reported case of simultaneous uveitis in monozygotic twins with confirmed sarcoidosis in one.

## Key findings

- Twin A had sarcoidosis confirmed by biopsy and showed granulomatous uveitis and lymphadenopathy.
- Twin B had non-granulomatous uveitis and retinal vasculitis, but no sarcoidosis was confirmed.
- A likely pathogenic SYNGAP1 duplication was found, linked to intellectual developmental disorder.

## Abstract

To report a case of two monozygotic twins presenting with simultaneous onset of bilateral uveitis of variable phenotypic presentations, one of whom was pathologically confirmed to have sarcoidosis.

Two 21-year-old monozygotic male twins (Twin A and Twin B) presented with bilateral red eyes and photophobia of six weeks’ duration. Their past medical history included learning difficulties and low IQ since early childhood. Twin A was operated for Celiac Artery Compression Syndrome. Examination and work-up revealed that Twin A had bilateral anterior granulomatous uveitis, and retinal phlebitis in addition to hilar and mediastinal lymphadenopathy. A biopsy was taken, and histopathological examination showed non-caseating granuloma. Twin B had bilateral non-granulomatous anterior uveitis, chorioretinal lesions, and peripheral retinal vasculitis. Genetic testing in the form of a Whole Exome Sequencing was done, and no causal variant was detected for uveitis or sarcoidosis, however, a homozygous likely pathogenic duplication in SYNGAP1 was detected. This mutation is associated with autosomal dominant intellectual developmental disorder.

This is the first-reported case of concurrent bilateral uveitis in monozygotic twins, with confirmed sarcoidosis in one. This presentation highlights the role of genetic predisposition and shared environmental factors in disease onset and clinical manifestations. Further research into the genetic-environmental interplay is needed to elucidate the mechanisms underlying simultaneous disease onset and guide personalized monitoring strategies for at-risk families.